Evidence map›Paper›PMID 30467022›Full record

ArticleThe lancet. HIV2018

National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.

Beth A Tippett Barr, Monique van Lettow, Joep J van Oosterhout, Megan Landes, Ray W Shiraishi, Ermias Amene, Erik Schouten, Nellie Wadonda-Kabondo, Sundeep Gupta, Andrew F Auld and 2 more

Abstract read
In one paragraph

Article in The lancet. HIV, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Beth A Tippett BarrDivision of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Lilongwe, Malawi; Center for Global Health, Centers for Disease Control and Prevention, Kisumu, Kenya. Electronic address: btippettbarr@cdc.gov.
Monique van LettowDignitas International, Zomba, Malawi.
Joep J van OosterhoutDignitas International, Zomba, Malawi; Department of Medicine, College of Medicine, University of Malawi, Blantyre, Malawi.
Megan LandesDignitas International, Zomba, Malawi; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.
Ray W ShiraishiDivision of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ermias AmeneDivision of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA; ICF International, Atlanta, GA, USA.
Erik SchoutenManagement Sciences for Health, Lilongwe, Malawi.
Nellie Wadonda-KabondoDivision of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Lilongwe, Malawi.
Sundeep GuptaDivision of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Lilongwe, Malawi; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Andrew F AuldDivision of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Lilongwe, Malawi.
Thokozani KaluaDepartment of HIV and AIDS, Malawi Ministry of Health, Lilongwe, Malawi.
Andreas JahnDepartment of HIV and AIDS, Malawi Ministry of Health, Lilongwe, Malawi; International Training and Education Center for Health, University of Washington, Seattle, WA, USA.

Funding

Intramural CDC HHS CC999999PEPFAR
6 · The paper itself

Abstract

backgroundRoutine data from Malawi's prevention of mother-to-child transmission (MTCT) option B+ programme suggest high uptake of antiretroviral therapy (ART) among pregnant women. Malawi's Ministry of Health led the National Evaluation of Malawi's PMTCT Program to obtain nationally representative data on maternal ART coverage and prevention of MTCT effectiveness. Here, we present the early transmission data for infants aged 4-12 weeks.

methodsWe used a multistage cluster design to recruit a nationally representative sample of HIV-exposed infants and their mothers in Malawi. Between October 16, 2014, and May 17, 2016, we screened for HIV in all mothers attending an under-5 vaccination or outpatient sick-child clinic with infants aged 4-26 weeks at 54 health facilities selected across ten districts and four regional sampling zones. Infants with mothers identified as HIV-infected were enrolled in the cohort. We calculated weighted MTCT rates for only the subset of infants aged 4-12 weeks at screening, thereby capturing MTCT from early pregnancy, to delivery, and early breastfeeding. We collected data on maternal and infant demographics and self-reported use of HIV services, ART, and antenatal clinics. We tested HIV-exposed infants for the virus and assessed associations of certain variables with infant HIV status.

findingsWe confirmed HIV exposure in 3542 (10·4%) of 33 980 mother (guardian)-infant pairs with infants aged 4-26 weeks. Of those, 2530 (2514 mothers and 16 guardians) had infants aged 4-12 weeks at the time of screening (2498 singlets and 32 twins). We excluded 25 infants from the analysis because no information was available about their HIV status. 91·3% (95% CI 85·6-96·9) of mothers were on ART during pregnancy. The MTCT rate was 3·7% (2·3-6·0) overall and ranged from 1·4% (0·4-4·4) in women who initiated ART before pregnancy to 19·9% (13·4-28·6) in women not on ART. In multivariable logistic regression analysis, the odds of early MTCT were higher in mothers starting ART post partum (adjusted odds ratio 16·7, 95% CI 1·6-171·5; p=0·022) and in those not on ART with an unknown HIV status during pregnancy (19·1, 8·5-43·0; p<0·0001) than in mothers on ART before pregnancy. Among HIV-exposed infants, 98·0% (95% CI 96·9-99·1) were reported by the mother to have received infant nevirapine prophylaxis, and only 45·6% (34·8-56·4) were already enrolled in an exposed infant HIV care clinic at the time of study screening.

interpretationThese data suggest that Malawi's decentralisation of ART services has resulted in higher ART coverage and lower early MTCT. However, the uptake of services for HIV-exposed infants remains suboptimal.

fundingPresident's Emergency Plan for AIDS Relief.

Indexed as

Health Services ResearchAnti-Retroviral AgentsCohort StudiesCommunicable Disease ControlCross-Sectional StudiesFacilities and Services UtilizationFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalMalawiPregnancyProcedures and Techniques UtilizationRisk FactorsAnti-Retroviral Agents

Identifiers

PMID30467022
PMCPMC6411682

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.